Biomx Inc

PHGE13 Dec 2024
Healthcare
$0.63
+0.00 (+0.30%)
Lowest Today
$0.63
Highest Today
$0.63
Today’s Open
$0.63
Prev. Close
$0.63
52 Week High
$8.55
52 Week Low
$0.48
To Invest in Biomx Inc

Biomx Inc

Healthcare
PHGE13 Dec 2024
+0.00 (+0.30%)
1M
3M
6M
1Y
5Y
Low
$0.62
Day’s Range
High
$0.63
0.62
52 Week Low
$0.48
52-Week Range
52 Week High
$8.55
0.48
1 Day
-
1 Week
+6.44%
1 month return
-4.59%
3 month return
-33.89%
6 month return
+103.86%
1 Year return
+136.24%
3 Years return
-64.81%
5 Years return
-92.72%
10 Years return
-

Market Status

Fundamentals
Market Cap
11.72 mln
PB Ratio
0.61
PE Ratio
0
Enterprise Value
16.58 mln
Total Assets
25.03 mln
Volume

Company Financials

Fund house & investment objective

Company Information
BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Organisation
Biomx Inc
Employees
58
Industry
Biotechnology
CEO
Mr. Jonathan Eitan Solomon MBA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities